DaVita Net Worth 2010-2025 | DVA

Interactive chart of historical net worth (market cap) for DaVita (DVA) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. DaVita net worth as of July 11, 2025 is $10.76B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.763B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.765B 18.49
Encompass Health (EHC) United States $11.937B 25.31
Elanco Animal Health (ELAN) United States $7.400B 15.85
Chemed (CHE) United States $6.728B 21.15
Option Care Health (OPCH) United States $4.893B 21.81
RadNet (RDNT) United States $4.163B 264.19
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.041B 22.41
LifeStance Health (LFST) United States $1.754B 0.00
Astrana Health (ASTH) United States $1.396B 34.58
U.S Physical Therapy (USPH) United States $1.132B 29.22
Pennant (PNTG) United States $0.870B 31.94
Aveanna Healthcare Holdings (AVAH) United States $0.792B 45.11
Atai Life Sciences (ATAI) Germany $0.525B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00